What is the long-term outlook and management for someone with Alport syndrome?

[Anonymous]

What is the long-term outlook for someone with Alport syndrome, and what ongoing monitoring is recommended?

[Genetic Counselor]

The long-term outlook for Alport syndrome varies enormously and depends on three things: which gene is involved, the inheritance pattern, and, within X-linked Alport syndrome specifically, the exact type of variant a person carries. As a general pattern, males with X-linked Alport syndrome caused by a variant that stops the protein from being made at all tend to reach kidney failure earliest, often by their teens or twenties, while those with a variant that only subtly changes the protein tend to progress more slowly, often not reaching kidney failure until their forties. Individuals with autosomal recessive Alport syndrome tend to have a course similar to severely affected males, regardless of their sex, while those with autosomal dominant Alport syndrome and most female carriers of X-linked Alport syndrome tend to have a much slower course, sometimes never reaching kidney failure at all. Because of this wide range, genetic testing that identifies the specific gene and variant is valuable not only for confirming the diagnosis but for giving a family a realistic sense of what to expect and when treatment should begin.

Lifelong, regular follow-up is recommended across all three affected organ systems, with the exact schedule adjusted to how significantly each person is affected:
• Kidneys. Urine testing for blood and protein, blood pressure measurement, and blood tests of kidney function are recommended every six months to one year for individuals with a confirmed diagnosis, and roughly every one to two years for carriers who show only isolated microscopic blood in the urine with no protein.
• Hearing. A hearing test, called an audiogram, is recommended yearly through childhood and adolescence for males with X-linked Alport syndrome and for individuals with autosomal recessive Alport syndrome, then roughly every three years in adulthood; carriers are generally tested only if they notice hearing changes themselves.
• Eyes. An eye examination is recommended at the time of diagnosis, with periodic follow-up thereafter for those with X-linked or autosomal recessive Alport syndrome; carrier relatives rarely need repeat eye examinations unless a problem is found at the first one.
• Kidney transplant recipients are monitored more closely, including regular blood testing for anti-glomerular basement membrane antibodies during the first year after transplant, when the rare rejection complication described above is most likely to appear.

Because relatives who carry a single altered gene copy can still show slow, silent kidney changes over decades, current guidance also recommends caution before such a relative donates a kidney to a family member, and this is a topic worth raising directly with the kidney transplant team when it becomes relevant.

[Author]

Posts